Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS

Primary T-cell CNS lymphoma is a rare and aggressive malignancy. High-dose methotrexate (MTX) based chemotherapy regimens are used as standard first-line treatment, followed by consolidative strategies to improve the duration of response. Although MTX-based therapy has been shown to be efficacious,...

Descrición completa

Detalles Bibliográficos

Principais autores:	Andy Liu, Huda Alalami, Xuemo Fan, Chirag Patil, Jaya M Gill, Santosh Kesari, Jethro Hu
Formato:	Artigo
Idioma:	Inglês
Publicado:	Taylor & Francis Group 2023-09-01
Series:	CNS Oncology
Assuntos:	case report PCNSL pemetrexed T cell T-cell lymphoma
Acceso en liña:	https://www.futuremedicine.com/doi/10.2217/cns-2022-0021
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!